Related references
Note: Only part of the references are listed.COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
Livio Pagano et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Immunogenicity and efficacy of heterologous ChAdOx1-BNT162b2 vaccination
Bruno Pozzetto et al.
NATURE (2021)
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
Rachna T. Shroff et al.
NATURE MEDICINE (2021)
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
Alfredo Addeo et al.
CANCER CELL (2021)
Seroconversion rates following COVID-19 vaccination among patients with cancer
Astha Thakkar et al.
CANCER CELL (2021)
Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma
Oliver Van Oekelen et al.
CANCER CELL (2021)
Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
Mario Mairhofer et al.
CANCER CELL (2021)
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer et al.
LANCET (2020)